TitusPullo - As long as the drugs and companies play nicely...

TitusPullo - As long as the drugs and companies play nicely together, then combinations may be just the ticket until a knockout drug comes along.

Suhm - has any info been released about the post treatment adverse event? Such as what symptoms deteriorated. The patient could have had a significant decline during treatment, but PBT2 was treating\masking the effects. Once PBT2 was ceased, the underlying problems returned to the level they would have been at if there had been no treatment at all. Pure conjecture, but it does beg the question of whether it caused the accelerated decline or masked an accelerated decline.


Cheers - a hopeful pessimist.